International guidelines recommend screening for hypergonadotropic hypogonadism in girls lacking secondary sexual characteristics by the age of 12, or experiencing primary amenorrhea by the age of 14, measuring follicle-stimulating hormone (FSH), LH and 17-beta-estradiol levels (47). This evidence concerns the gene BRD2 and Hypergonadotropic hypogonadism.